Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $373K 11.1K sh | Nov 4, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $63K 1,129 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $118K 295 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $164K 410 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $176K 432 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Kasbar Michael JDirector, Executive Chairman |  WKCWORLD KINECT CORPOpen-market sale · 10b5-1 plan | SELL | $292K 8,062 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $799K 26.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Raketich Kevin AEVP, Strategy & Corp. Dev. |  MTUSMetallus Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,080 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $160K 1,417 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $219K 1,992 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $124K 1,117 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $114K 1,063 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $125K 1,130 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $159K 1,482 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $60K 536 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Ledingham DianneDirector |  PEGAPEGASYSTEMS INCOpen-market sale · 10b5-1 plan | SELL | $34K 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 974 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | Williams Michael SDirector, Chief Executive Officer | MTUSMetallus Inc. Open-market sale · 10b5-1 plan | SELL | $22K 985 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $160K 1,417 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Pieper StevenSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $51K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $998K 21.4K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 14 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOpen-market sale · 10b5-1 plan | SELL | $40K 600 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Jampol ThadChief Product Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $210K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $302K 2,667 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $302K 2,667 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $595K 11.6K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $612K 12.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 14 | McCulloch KevinSee Remarks | XERSXeris Biopharma Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $153K 15.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $301K 6,197 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 14 | Hancock MarkDirector, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $605K 11.8K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO |  VRSNVERISIGN INC/CAOpen-market sale · 10b5-1 plan | SELL | $119K 380 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $35K 662 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Raabe Kyle AndrewPresident, Home Power Gen. |  GNRCGENERAC HOLDINGS INC.Open-market sale · 10b5-1 plan | SELL | $81K 386 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $8,146 21 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K